AMANDA MARIE CROSSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology VENICE, FL NPI 1568024537
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology FL Merck Sharp & Dohme Corporation All categories
General Payments — all program years on this page
$5,806.91
- Category: General Payments
- Program years: PY2021–2024
- Record count: 245
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,143.80 across 40 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,043.81 | 39 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $157.74 | 6 |
| Bayer HealthCare Pharmaceuticals Inc. | $150.30 | 2 |
| Astellas Pharma US Inc | $141.41 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $64.36 | 3 |
| Daiichi Sankyo Inc. | $56.90 | 2 |
| PFIZER INC. | $56.38 | 2 |
| GlaxoSmithKline, LLC. | $46.34 | 2 |
| Acerta Pharma LLC | $44.42 | 2 |
| Sumitomo Pharma America, Inc. | $39.00 | 2 |
| ABBVIE INC. | $36.68 | 2 |
| Celgene Corporation | $36.64 | 1 |
| Gilead Sciences, Inc. | $29.86 | 1 |
| SpringWorks Therapeutics, Inc. | $28.57 | 1 |
| ADC Therapeutics America, Inc. | $26.56 | 1 |
| Exelixis Inc. | $26.42 | 1 |
| Blueprint Medicines Corporation | $25.90 | 1 |
| EISAI INC. | $25.85 | 1 |
| Incyte Corporation | $25.81 | 1 |
| Fennec Pharmaceuticals, Inc. | $23.44 | 1 |
| Pharmacosmos Therapeutics Inc. | $22.63 | 1 |
| Myriad Genetic Laboratories, Inc. | $21.05 | 1 |
| Coherus Biosciences Inc. | $20.95 | 1 |
| Janssen Biotech, Inc. | $20.06 | 1 |
| Solventum Corporation | $16.53 | 1 |
By program year
Records — PY2024 (40)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.